Acetaminophen

Evidence Level: N/A Predicted Indications: 0

Table of Contents

  1. Acetaminophen
    1. Pharmacist Assessment Report
    2. Acetaminophen: Known uses and market status in India
    3. Summary
    4. Quick overview
    5. Known uses among the model’s candidates
      1. Approved (supported by a licence or label)
      2. Related to an approved indication (same disease category)
      3. Relations recorded in the knowledge graph (no approval found)
    6. India Market Information
    7. Safety Considerations
    8. Disclaimer

Pharmacist Assessment Report

Acetaminophen: Known uses and market status in India

Summary

The TxGNN deep-learning model (score ≥ 0.99) produced candidate indications for Acetaminophen. Every candidate that can be traced to a source is already a known use. There is therefore currently no new predicted indication for this drug.

Quick overview

Item Content
New predicted indications None (all traceable model candidates are known uses)
Known uses among model candidates 0
Evidence level Not applicable
India Market Status Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data
Number of Listed Products at least 20

Known uses among the model’s candidates

Approved (supported by a licence or label)

Indication Source
none none
Indication Approved category
none none

Relations recorded in the knowledge graph (no approval found)

Indication
none

India Market Information

Licence Product Dosage form Status
150248 Myospaz Tablet strip of 10 tablets Valid
35707 Capagin Tablet strip of 10 tablets Valid
205519 Solmol 500 Tablet strip of 10 tablets Valid
39882 Curadol 650 Tablet strip of 10 tablets Valid
2075 A Mol 650mg Tablet strip of 10 tablets Valid
176026 Pamol 650mg Tablet strip of 10 tablets Valid
86262 Febrinil P 250 mg/2.5 mg Syrup bottle of 60 ml Syrup Valid
1663 Aeknil Injection vial of 15 ml Injection Valid
12677 Aipara 650mg Tablet strip of 10 tablets Valid
150768 Neomol 170 Anal Suppository packet of 5 suppositories Valid
210731 Smopara 650mg Tablet strip of 10 tablets Valid
221774 Terizine Plus Tablet strip of 10 tablets Valid
180619 Pararite 650mg Tablet strip of 10 tablets Valid
177793 Pro Kid Syrup bottle of 60 ml Syrup Valid
250650 Zuby Kid Drop packet of 15 ml Drop Valid
181886 Pecomol 500mg/5mg Tablet strip of 10 tablets Valid
69710 Dotopar 650mg Tablet strip of 10 tablets Valid
9607 Antimol 500 Tablet strip of 10 tablets Valid
160472 Nettmol 250mg Oral Suspension bottle of 60 ml Oral Suspension Valid
207713 Soparin Kid 125mg Tablet DT strip of 10 tablet dt Valid

Only part of the licence list is held in the data; the list may be incomplete.

Safety Considerations

  • Contraindications (TxGNN model output): liver failure, liver disease, gallbladder disease, cirrhosis of liver, hepatic encephalopathy, hepatic coma. These come from the TxGNN model (deep learning) and may reflect similarities the model learned between related diseases, not biological evidence; they are not from label text.
  • Drug Interactions: 277 interactions were recorded. Most are minor, and the main ones are:
    • Moderate: activated charcoal, glycerol phenylbutyrate, naltrexone
    • Minor: several anticholinergic and antispasmodic agents (atropine, dicyclomine, hyoscyamine, scopolamine, glycopyrronium and others), H2 blockers (cimetidine, ranitidine), metoclopramide and liraglutide

Please refer to the package insert for full warnings and contraindications.

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



This site uses Just the Docs, a documentation theme for Jekyll.